These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33358412)

  • 1. Office- or Facility-Based Probing for Congenital Nasolacrimal Duct Obstruction: A Report by the American Academy of Ophthalmology.
    Morrison DG; Binenbaum G; Chang MY; Heidary G; Trivedi RH; Galvin JA; Pineles SL
    Ophthalmology; 2021 Jun; 128(6):920-927. PubMed ID: 33358412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing for congenital nasolacrimal duct obstruction.
    Petris C; Liu D
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011109. PubMed ID: 28700811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balloon Dacryoplasty for Congenital Nasolacrimal Duct Obstruction: A Report by the American Academy of Ophthalmology.
    Wladis EJ; Aakalu VK; Yen MT; Bilyk JR; Sobel RK; Mawn LA
    Ophthalmology; 2018 Oct; 125(10):1654-1657. PubMed ID: 29887332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction.
    Pediatric Eye Disease Investigator Group
    Arch Ophthalmol; 2012 Dec; 130(12):1525-33. PubMed ID: 23229693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Office probing for treatment of nasolacrimal duct obstruction in infants.
    Miller AM; Chandler DL; Repka MX; Hoover DL; Lee KA; Melia M; Rychwalski PJ; Silbert DI; ; Beck RW; Crouch ER; Donahue S; Holmes JM; Quinn GE; Sala NA; Schloff S; Wallace DK; Foster NC; Frick KD; Golden RP; Lambert SR; Tien DR; Weakley DR
    J AAPOS; 2014 Feb; 18(1):26-30. PubMed ID: 24568978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.
    Hung CH; Chen YC; Lin SL; Chen WL
    Pediatr Neonatol; 2015 Dec; 56(6):402-7. PubMed ID: 26026949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasolacrimal duct office probing in children under the age of 12 months: Cure rate and cost evaluation.
    Le Garrec J; Abadie-Koebele C; Parienti JJ; Molgat Y; Degoumois A; Mouriaux F
    J Fr Ophtalmol; 2016 Feb; 39(2):171-7. PubMed ID: 26826746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of treatment approaches for bilateral congenital nasolacrimal duct obstruction.
    Lee KA; Chandler DL; Repka MX; Melia M; Beck RW; Summers CG; Frick KD; Foster NC; Kraker RT; Atkinson S;
    Am J Ophthalmol; 2013 Nov; 156(5):1045-50. PubMed ID: 23954210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Office probing for congenital nasolacrimal duct obstruction: a study of parental satisfaction.
    Goldblum TA; Summers CG; Egbert JE; Letson RD
    J Pediatr Ophthalmol Strabismus; 1996; 33(4):244-7. PubMed ID: 8827561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of probing for congenital nasolacrimal duct obstruction in older children.
    Honavar SG; Prakash VE; Rao GN
    Am J Ophthalmol; 2000 Jul; 130(1):42-8. PubMed ID: 11004258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of 2 approaches to managing nasolacrimal duct obstruction in infants: the importance of the spontaneous resolution rate.
    Frick KD; Hariharan L; Repka MX; Chandler D; Melia BM; Beck RW;
    Arch Ophthalmol; 2011 May; 129(5):603-9. PubMed ID: 21555614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Inferior Turbinate Fracture in the Management of Congenital Nasolacrimal Duct Obstruction.
    Rajabi MT; Inanloo B; Salabati M; Rafizadeh M; Tabatabaie SZ; Bayat R; Mahmoudzadeh R
    Ophthalmic Plast Reconstr Surg; 2019; 35(3):269-271. PubMed ID: 30234839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early office-based vs late hospital-based nasolacrimal duct probing. A clinical decision analysis.
    Kassoff J; Meyer DR
    Arch Ophthalmol; 1995 Sep; 113(9):1168-71. PubMed ID: 7661751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endonasal dacryocystorhinostomy: a report by the American Academy of Ophthalmology.
    Woog JJ; Kennedy RH; Custer PL; Kaltreider SA; Meyer DR; Camara JG
    Ophthalmology; 2001 Dec; 108(12):2369-77. PubMed ID: 11733286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Success rates of probing for congenital nasolacrimal duct obstruction at various ages.
    Świerczyńska M; Tobiczyk E; Rodak P; Barchanowska D; Filipek E
    BMC Ophthalmol; 2020 Oct; 20(1):403. PubMed ID: 33032542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of initial and repeated nasolacrimal duct office-based probing for congenital nasolacrimal duct obstruction.
    Cha DS; Lee H; Park MS; Lee JM; Baek SH
    Korean J Ophthalmol; 2010 Oct; 24(5):261-6. PubMed ID: 21052504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric nasolacrimal duct obstruction.
    Schnall BM
    Curr Opin Ophthalmol; 2013 Sep; 24(5):421-4. PubMed ID: 23846190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Office probing of congenital nasolacrimal duct obstruction.
    Stager D; Baker JD; Frey T; Weakley DR; Birch EE
    Ophthalmic Surg; 1992 Jul; 23(7):482-4. PubMed ID: 1407947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Office-Based Nasolacrimal Duct Probing.
    Bach A; Vanner EA; Warman R
    J Pediatr Ophthalmol Strabismus; 2019 Jan; 56(1):50-54. PubMed ID: 30371916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
    Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
    Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.